The ReachMD Network powers its channels through a proprietary Connected Insights Ecosystem®, featuring content personalization, marketing automation, AI-initiated recommendations, time in media tracking, radio customization, and more.
“Practical Dermatology joining the ReachMD Network is a logical next step for this invaluable publication,” said Dik Barsamian, President of ReachMD. “Dermatologists are able to watch, listen to, or read thousands of programs that improve their patient care strategies.”
Practical Dermatology features world-renowned experts who address a wide range of dermatology topics and relate the scientific findings in such a way that is applicable to patient care. It is one of ten specialty sites to join the ReachMD Network, ensuring clinicians across the globe gain access to best-in-class digital learning experiences.
ABOUT REACHMD
ReachMD is an education technology platform that helps healthcare professionals discover, participate in, and share medical education, events, and clinical information. With a library of more than 10,000 professional education programs, ReachMD is the leading source for education on clinical research, medical practice, disease management, and patient care strategies. Voted ‘Best Healthcare Professional Media Brand’ by Medical Marketing & Media (MM+M) multiple times since 2010 —including back-to-back Gold wins in 2020, 2021, 2022, 2023 — ReachMD provides the world’s most media-rich learning platform with data insights on healthcare professionals. Visit Practical Dermatology at www.practicaldermatology.com
CMFlex, the first 3D-printed regenerative bone product cleared by the FDA, is a ready-to-use, flexible ceramic graft created for bone reconstruction. It is currently indicated for procedures in the mid to lower face, with expanded indications anticipated. CMFlex offers an innovative, fully synthetic regenerative solution that leverages a distinctive material microstructure and macroarchitecture designed for rapid vascularization and tissue integration to promote bone regeneration and remodeling.
“This groundbreaking innovation is a testament to the hard work, dedication, and expertise of our incredible team. Their relentless pursuit of excellence has made CMFlex a reality, offering a truly novel product that improves clinician workflow, reduces surgical case time, and restores healthy bone. We’re excited by the interest we’ve already received from surgeons who recognize its innovative design that optimizes both biological function and ease of use,” said Ramille Shah, Ph.D., CSO, Head of R&D, and co-founder of Dimension Inx.
The Innovation by Design Awards honor the designers and businesses solving the most crucial problems of today and anticipating the pressing issues of tomorrow. It is one of the most sought-after design awards in the industry. Entries are judged on the key ingredients of innovation: functionality, originality, beauty, sustainability, user insight, cultural impact, and business impact.
Winners, finalists, and honorable mentions are featured online, and winners and finalists are featured in the Summer issue of Fast Company magazine, on newsstands July 30, 2024. To see the complete list, go to https://www.fastcompany.com/innovation-by-design/list.
ABOUT DIMENSION INX
Dimension Inx is a tissue therapeutics company. We design, develop, and manufacture regenerative solutions that restore tissue and organ function to provide life-saving solutions for patients facing currently incurable diseases like type 1 diabetes and liver disease.
Our materials-centric approach enables biofunctionality without compromising manufacturability. We precisely tune our biomaterials to create clinical solutions not otherwise possible. We work shoulder-to-shoulder with biotech partners to help solve their most challenging materials problems, and internally develop regenerative products for therapeutic applications with high unmet clinical need.
As President, Fink will oversee Slone Partners’ marketing, finance, human resources, consulting services, and strategic growth areas, including fractional talent placements. He will work alongside Chief Executive Officer and Managing Partner Leslie Loveless and Founder and Chairman Adam Slone to scale the company through new business models and initiatives. Additionally, Fink will collaborate closely with Chief Operating Officer (COO) Alicia Montgomery to enhance the company’s business practices and systems to ensure the most effective, quality-oriented, and efficient client experience.
“Eric Fink is an extremely accomplished industry leader with deep expertise in almost all facets of business operations and growth strategies,” said Loveless. “He joins our leadership team at a pivotal time in our evolution as we expand our line of recruiting and advisory services and integrate AI into our operational infrastructure to enrich the client and candidate experience.”
“I am excited to join the incredible team at Slone Partners. It is clear that we are aligned on a dynamic vision for building upon the company’s remarkable success to date, and I am eager to explore new growth opportunities and enhance our business model efficiencies,” said Fink. “Fractional talent and AI are two key areas where we can significantly enhance our offerings and operations to better serve our client partners in the near term.”
Prior to joining Slone Partners, Fink served as COO of ABio-X Holdings, a private Boston-based investment and incubation company, where he built and scaled the G&A and operating functions of the company and its portfolio companies. Before that, Fink served as Chief Human Resources Officer at Silence Therapeutics; Chief Human Resources Officer at Freeline Therapeutics; Executive Vice President, Chief Human Resources Officer at Global Blood Therapeutics; and in a variety of leadership roles ending as Vice President, Human Resources at Jazz Pharmaceuticals.
Fink earned his B.S. in Biology from Pennsylvania State University and his M.S. in Organizational Leadership from Mercyhurst College.
ABOUT SLONE PARTNERS Founded in 2000, Slone Partners is a premier executive search firm that delivers visionary leaders who build amazing life sciences and healthcare organizations. With a nationwide presence in the most active industry hubs, we specialize in discovering and placing world-class Board, C-Suite leadership, and upper management talent with experience, conviction, and cultural competence in emerging and well-established companies. Our portfolio of executive search and advisory services includes customized cultural solutions through strategic planning, education, training, and coaching. Slone Partners proudly holds the designation as a Certified LGBT Business Enterprise™ by the National Gay & Lesbian Chamber of Commerce (NGLCC) and has earned recognition as a Top Executive Search Firm and a Top 20 Diversity and Inclusion Services firm by Manage HR. To learn more about Slone Partners’ value proposition and processes, visit https://www.slonepartners.com or call 888.784.3422.
The article notes that these judicial observations have cast a more favorable light on SpineFrontier, Impartial Medical Experts LLC (IME) and Dr. Chin, suggesting that the evidence may not be as clear-cut as initially presented.
About Law360: Law360 is a leading legal news and analysis service, providing in-depth coverage of major litigation across various sectors, including healthcare. The article by Brian Dowling offers a comprehensive overview of the recent judicial comments and their implications for the ongoing case against SpineFrontier, Impartial Medical Experts LLC (IME) and Dr. Kingsley R. Chin.
“Welcoming USGIF as an Event Partner for Geo Week is truly exciting and represents the collaborative ecosystem in the geospatial industry. The inclusion of USGIF will further attract and benefit prominent thought leaders in the geospatial intelligence field and foster enhanced networking, collaboration, and idea-sharing among industry experts,” said Lee Corkhill, Group Event Director at Diversified Communications, the organizer of Geo Week. “Our partnership with dedicated and passionate organizations like USGIF makes Geo Week a premier platform for cultivating connections and advancing the industry.”
The USGIF membership comprises a dynamic and diverse community of nearly 300 corporate, federal, and academic entities, united with tens of thousands of the nation’s brightest leaders. This collaborative network is dedicated to advancing the GEOINT field through shared expertise, innovative solutions, and a commitment to addressing both current and future challenges. By fostering connections and facilitating knowledge exchange, USGIF members play a pivotal role in driving the GEOINT community forward, enhancing national security, and contributing to the global geospatial landscape.
Full event information will be available soon, including workshops, conference programming, networking events, and more. Registration opens in October. To stay up to date, fill out the Attendee Inquiry form.
About the United States Geospatial Intelligence Foundation
The United States Geospatial Intelligence Foundation (USGIF) is a 501(c)(3) non-profit educational foundation dedicated to promoting the geospatial intelligence tradecraft and developing a stronger GEOINT community across industry, academia, government, and professional organizations. USGIF achieves its mission via its strategic pillars: Build the Community | Advance the Tradecraft | Accelerate Innovation. For more information, visit https://usgif.org/.
About Geo Week
Geo Week, presented by Geo Weeks News, was created in response to the changing needs of the built world and geospatial professionals and to acknowledge the increasing convergence of technology. Geo Week’s conference program and tradeshow floor feature commercial applications of 3D technologies, innovations, and case studies in the built environment, advanced airborne and terrestrial remote sensing solutions, smart products for a full project team, and more. Multiple strategic partnerships, including Conference and Event Partners ASPRS and RCN, plus Event Partners ISPRS, MAPPS, USGIF, USIBD, and WGIC strengthen Geo Week. Geo Week occurs February 10-12, 2025, at the Colorado Convention Center, Denver, CO. For more information, visit https://www.geo-week.com/.
Geo Week is produced by Diversified Communications’ technology portfolio, which also includes Commercial UAV News; Geo Week, Geo Week Newsletter, 3D Technology Newsletter, AEC Innovations Newsletter, Geo Business (UK) and Digital Construction Week (UK).
For more information about exhibiting at the Geo Week, visit the Exhibitor Information page or contact Casey Reynolds, Sales Manager, at [email protected] or (207) 842-5624 or Dominique Caron, Sales Representative, at [email protected] or (207) 842-5404. For Attendee Inquiries, visit the Attendee Inquiry page or email [email protected].
Questions?
Lora Burns, Geo Week Senior Marketing Manager, [email protected] Kristen Kloster-Grady, USGIF Director of Communications, [email protected]
“We write – firmly united – as pharmacies and pharmacists across all practice settings.
“We extend our deepest gratitude and strongest encouragement for your continued bipartisan scrutiny of the practices of some market-dominant pharmacy benefit manager (PBM) middlemen that inflate Americans’ prescription drug costs, force pharmacy closures, and block access to Americans’ pharmacies of choice.
“Speaking with one voice, we also urge the U.S. Congress to send to President Biden’s desk this year the must-pass PBM reforms in Medicare, Medicaid, and the commercial markets that at long last would confront these harmful practices, and that have advanced on a bipartisan basis in the U.S. House of Representatives and the U.S. Senate.
“Throughout the Committee on Oversight and Accountability’s investigation, our organizations and individual members have provided examples and insights about concerning PBM practices and their harms. Pharmacies and pharmacists have experienced and warned about these tactics for upwards of 15 years. Unabated and unchecked by federal action, these tactics and their devastating effects have escalated consistently and severely – and they have reached even new extremes in 2024.
“As is now widely known, every day that passes without reform means more dollars flowing to PBMs instead of reducing Americans’ prescription drug costs and safeguarding access to trusted and convenient pharmacies.
“Thankfully, recognition of some dominant PBMs’ devastating practices today is prevalent among Republicans and Democrats, conservatives and progressives, federal and state governments, employers, unions, patient groups, providers, rural and urban health advocates, and diverse media outlets.
“It is past time for action.
“Throughout the 118th Congress, we have articulated clearly pharmacies’ legislative priorities that are necessary to confront the harms that are ravaging Americans and their pharmacies. The following aspects of reform are absolutely necessary to ensure that a reform package is effective and that it can be supported by pharmacies:
Medicaid managed care pharmacy payment reform and a ban on spread pricing by requiring 100% pass-through to the pharmacy of the ingredient cost and of the professional dispensing fee, which could allow the federal government and states to save billions of dollars.
o Ensuring fair and adequate Medicaid managed care pharmacy reimbursement from PBMs to cover the cost to acquire and dispense prescription drugs.
o Requiring National Average Drug Acquisition Cost (NADAC) survey participation to help establish benchmarks for Medicaid reimbursement to retail pharmacies which can be used to ensure fair reimbursement to pharmacies in Medicaid managed care and in the commercial markets.
Requiring the Centers for Medicare and Medicaid Services (CMS) to define and enforce “reasonable and relevant” Medicare Part D contract terms, including information about reimbursement and dispensing fees, and establishing in Medicare Part D an approach by which “any willing pharmacy” can truly participate and serve patients.
“These, along with additional policies have been the subject of bipartisan and bicameral work across key committees of jurisdiction, creating a robust package of Medicare, Medicaid, and commercial market reforms that also include:
Promoting transparency of insurer claims and reimbursement information to the pharmacy, including independent audits and enforcement measures in Medicare Part D.
“Again, we thank the Committee for its diligent investigation and we urge the Congress’ enactment this year of what should be considered must-pass legislation: PBM reforms which the Congress has developed and which Americans and their pharmacies desperately await.”
More information about the pharmacy organizations is available online:
CALISPN Launches New Online Mental Health and Wellness Directory The California Suicide Prevention Network (CALISPN) has launched n directory to support mental well-being and prevent suicide among veterans, entrepreneurs, and entertainment professionals in Los Angeles. Spearheaded by Katisha Jallow, this initiative connects individuals with tailored mental health resources and advocates for community collaboration in mental wellness efforts. CALISPN does not provide clinical services or referrals. CaliSPN is not a crisis center.
LOS ANGELES, July 22, 2024 /PRNewswire-PRWeb/ — California Suicide Prevention Network (CALISPN).is proud to announce the relaunch their online mental health and wellness members directory. This groundbreaking initiative aims to enhance mental well-being and prevent suicide among key groups within Los Angeles County, including assisting military veterans, entrepreneurs, and professionals in the film, media, and entertainment industries to reach out to those advocates and professionals who all specialist in health and wellness.
The CALISPN online directory serves as a comprehensive platform for tailored mental health services and resources. It is designed to connect individuals with a network of mental health professionals and advocates, offering specialized support to those facing unique challenges within these communities.
“Our mission is to foster a supportive environment that promotes mental wellness and addresses the specific needs of our targeted communities,” said Katisha Jallow, Founder of CALISPN. “By providing a centralized resource hub, we aim to improve access to mental health support and encourage collective action towards suicide prevention.”
The CALISPN directory will feature listings for Mental Health Counselor Experts, Advocacy Agencies, Community Outreach Specialists, and Educators or Training Facilities. This initiative underscores the importance of collaboration between businesses, mental health professionals, and community members in advancing mental health and suicide prevention efforts.
Key Features of CALISPN:
Comprehensive Resource Hub: A one-stop platform for accessing mental health services and support.
Specialized Support: Tailored resources for military veterans, entrepreneurs, and professionals in creative industries.
Community Engagement: Opportunities for professionals and organizations to join advocacy efforts and outreach programs.
Katisha Jallow emphasizes the role of community engagement in achieving these goals: “We believe in the power of collaboration to build a healthier, more resilient community. Our directory provides a vital platform for professionals to showcase their services and connect with those in need.”
About Katisha Jallow: Katisha Jallow is Retired Army veteran with 24 years of active-duty service. She founded California Suicide Prevention Network (CALISPN) in 2018. Her diverse experiences and commitment to mental health advocacy have shaped her into a respected community leader and advocate. Katisha specializes in life coaching, awareness and training in – risk management, resiliency, suicide prevention, self-care while using her expertise to empower individuals and organizations.
CALISPN does not provide clinical services or referrals. CaliSPN is not a crisis center. If you are thinking of hurting yourself, or if you are concerned that someone you know may be suicidal, contact the https://988lifeline.org/chat/.
Dr. John Nicholas Melvan is a board-certified cardiothoracic surgeon with Memorial Cardiac and Vascular Institute, who performs both traditional surgeries and transcatheter procedures.
HOLLYWOOD, Fla., July 22, 2024 /PRNewswire-PRWeb/ — Dr. John Nicholas Melvan is a board-certified cardiothoracic surgeon with Memorial Cardiac and Vascular Institute who was previously a resident at Emory University’s School of Medicine. Dr. Melvan sees parallels between Emory’s place in Atlanta’s community and Memorial’s footprint in South Florida. “Both systems have an academic focus and are committed to growth, excellence, and continual improvement. There is also collaboration between like-minded individuals with the same goals.”
Dr. Melvan was initially exposed to various fields of medicine but found himself particularly drawn to surgery because of its immediate impact. His enthusiasm for the surgical field is amplified by ongoing medical advancements, particularly in minimally invasive techniques. Dr. Melvan, who performs both traditional surgeries and transcatheter procedures, was attracted to Memorial’s “long history of excellence, transparency, and quality outcomes.” Dr. Melvan believes in offering patients not only evidence-based, life-saving surgeries but also providing compassionate coaching throughout their medical journey.
Dealing with some of the sickest patients in the hospital, he says it’s important to have the resources to attack the most challenging cases and deliver next-level care. “Ours can be lifetime management of the patient’s cardiac problem(s). We’re sometimes planning for the second and third operations while doing the initial procedure.”
Memorial Cardiac & Vascular Institute is a cardiovascular care leader, offering a wide array of services dedicated to the prevention, detection, and treatment of heart and vascular conditions, including cardiology, electrophysiology, adult congenital heart disease, heart failure, heart surgery and heart transplant. Its combination of extraordinary medical expertise, advanced technology, and exacting quality guidelines deliver the best possible outcomes for those receiving care tailored to their specific needs.
Trusted Global Biospecimen Provider Enters New Geographical Markets To Support Diverse Clientele
IRVING, Texas, July 22, 2024 /PRNewswire-PRWeb/ — iProcess Global Research, a leader in clinical trial management and biospecimen supply, announces its strategic expansion into more countries across South America, Europe, and Asia. This expansion marks a significant milestone in iProcess’s commitment to extending its global footprint and enhancing support for clients in the life sciences sector.
iProcess Global Research has established new operational sites in additional key regions of South America, Europe, and Asia. These strategic locations have been chosen to capitalize on emerging market opportunities and to meet the growing demand for advanced clinical trial management services and biospecimen collection capabilities.
This expansion into more countries across South America, Europe, and Asia is expected to have an outsized impact on iProcess’s clientele worldwide. By establishing a local presence in these new countries, iProcess will provide enhanced accessibility and tailored assistance to regional clients. This support includes localized regulatory expertise, cultural sensitivity in research practices, and expanded biospecimen collection networks to better serve diverse healthcare needs.
Through its expansion, iProcess Global Research introduces new and enhanced services designed specifically for each region’s needs, such as comprehensive clinical trial management, advanced biospecimen testing, and innovative research collaborations. Its localized approach ensures clients benefit from personalized solutions and streamlined processes that adhere to global quality standards.
iProcess Global Research’s expansion into more countries across South America, Europe, and Asia underscores its dedication to advancing medical research and supporting global healthcare initiatives. By broadening its reach and enhancing service capabilities, iProcess is poised to foster new partnerships and drive innovation in the life sciences industry worldwide. For more information, check out their website.
About iProcess Global Research: Established in 2004, iProcess Global Research is a renowned leader in clinical trial management, biospecimen supply, and research collaborations spanning North America, Europe, South America, Africa, and Asia. With over two decades of dedicated experience and a steadfast commitment to excellence, iProcess remains at the forefront of advancing medical research and enhancing global patient outcomes.
2025 Richard V. Smalley Memorial Award and Lectureship Ira Mellman, PhD – Genentech
2024 Richard V. Smalley Memorial Award and Lectureship Elizabeth M. Jaffee, MD, FAIO, FAACR, FACP, FAAAS – Sidney Kimmel Cancer Center at Johns Hopkins
2024 SITC Lifetime Achievement Award Bernard A. Fox, PhD – Earle A. Chiles Research Institute, Providence Cancer Institute
2024 Tara Withington Public Service Award Deborah Collyar, B.Sci – Patient Advocates in Research (PAIR)
2024 Pedro J. Romero Service to JITC Award Andrea Kunz – Society for Immunotherapy of Cancer
To learn more about the Annual Awards and to view past recipients, visit SITC’s website. SITC will announce a call for nominations for the 2025 Annual Awards in the spring.
About SITC Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at sitcancer.org and follow us on X, LinkedIn, Facebook, Instagram and YouTube.
